Four things to know:
1. The companies said that the initial list price for the two drugs will be 15 percent lower than the price of their reference product.
2. Amgen launched Mvasi, a biosimilar to Avastin. It will be available at a wholesale cost of $677.4 per 100 milligrams and $2,709.60 for a single-dose vial.
3. Allergan has launched Kanjiti, a biosimilar to Herceptin. It will be available at $3,697.26 per 420-milligram vial.
4. Herceptin and Avastin together brought in sales of $5.8 billion in 2018 for Roche.
Read the full report here.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.